Non-Compartmental Analysis (NCA)
ورودیهای بالینی بیمار
حداقل ۰.۰۱ — حداکثر ۱۰۰۰۰۰
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Computed0–0
The Non-Compartmental Analysis (NCA) calculates calculating standardized physiological indices and stratifying general clinical risk. Key inputs include times. Scores guide individualizing bedside clinical management, scheduling routine follow-up, and monitoring clinical progress. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Non-compartmental pharmacokinetic analysis from a concentration-time profile: AUC (linear trapezoidal with extrapolated tail), elimination rate constant Ke (log-linear regression on terminal points), half-life, clearance (Dose/AUC), and volume of distribution (CL/Ke). Enter times with concentrations; the last 3 points define the terminal phase by default.
Clinical Indication
The Non-Compartmental Analysis (NCA) is indicated for bedside clinical practice to support Non-compartmental pharmacokinetic analysis from a concentration-time profile: AUC (linear trapezoidal with extrapolated tail), elimination rate constant Ke (log-linear regression on terminal points), half-life, clearance (Dose/AUC), and volume of distribution (CL/Ke). Enter times with concentrations; the last 3 points define the terminal phase by default.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Adult ambulatory and hospitalized patient cohorts evaluated for systemic illness, physiologic risk, or diagnostic probability. Clinical application is indicated across General medical-surgical inpatient units, primary care clinics, and ambulatory outpatient facilities.
Limitations & Contraindications
Single-point score values can obscure rapid temporal clinical deterioration; serial clinical reassessment is essential.
Clinical Pearls & Action Plan
Calculated indices must be contextualized alongside complete clinical history, physical exam, and dynamic trajectory.
AUC = trapezoidal + Clast/Ke; Ke = -slope(ln C vs t); CL = Dose/AUC; Vz = CL/Ke
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| times | array | Yes | Sample times in hours (comma-separated, increasing) |
| concentrations | array | Yes | Concentrations at those times (comma-separated) |
| dose | float | Yes | Dose administered in mg |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–0 | Computed | NCA parameters |
Evidence-Based References (EBM)
- Standard non-compartmental analysis: Gabrielsson J, Weiner D. Pharmacokinetic and Pharmacodynamic Data Analysis. (trapezoidal AUC, terminal Ke, CL, Vz)